Benefits and Drawbacks of the Use of Oral Fluoropyrimidines as Single-Agent Therapy in Advanced Colorectal Cancer
Jim CassidyVolume:
5
Year:
2005
Language:
english
DOI:
10.3816/ccc.2005.s.007
File:
PDF, 871 KB
english, 2005